CoChat

Fatty acids as metabolic mediators in innate immunity

Kopp, A., Gross, P., Falk, W., Bala, M., Weigert, J., Buechler, C., Neumeier, M., Schölmerich, J., Schäffler, A. · 2009 · European Journal of Clinical Investigation
Cited by 40

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background Increasing data support the hypothesis of a local and systemic crosstalk between adipocytes and monocytes mediated by fatty acids. The aim of this study was to characterize the immunomodulatory effects of a large panel of fatty acids on cytokines and chemokines in monocytic THP‐1 cells and primary human monocytes. We tested whether anti‐inflammatory fatty acids are able to inhibit the binding of lipopolysaccharide (LPS) to its receptor, toll‐like receptor/MD‐2 (TLR4/MD‐2). Materials and methods Resistin, monocyte chemoattractant protein‐1 (MCP‐1) and tumour necrosis factor (TNF) were measured by enzyme‐linked immunosorbent assay. Proteins were analysed by Western blot. A designed Flag‐tagged TLR4/MD‐2 fusion protein (LPS trap) was used to investigate the effect of fatty acids on binding of LPS to its receptor. In 30 patients with type 2 diabetes mellitus (T2D), the correlation of serum triglyceride levels with LPS‐induced monocyte activation was analysed. Results Eleven fatty acids investigated exerted differential effects on the monocytic release of cytokines and chemokines. Eicosapentaenoic acid had potent anti‐inflammatory effects on human primary monocytes and THP‐1 cells; 100 and 200 μM eicosapentaenoic acid dose‐dependently inhibited LPS binding to the LPS trap. LPS‐induced release of monocytic MCP‐1 and TNF was significantly and positively correlated with serum triglyceride levels in 30 patients with T2D. Conclusions Monocytic activation is differentially regulated by fatty acids and depends on triglyceride levels in T2D. The main finding of the present study shows that eicosapentaenoic acid inhibits the specific binding of LPS to TLR4/MD‐2. Eicosapentaenoic acid represents a new anti‐inflammatory LPS‐antagonist.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2009.02185.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 40

Metadata

Authors
Kopp, A., Gross, P., Falk, W., Bala, M., Weigert, J., Buechler, C., Neumeier, M., Schölmerich, J., & Schäffler, A.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2009-09-15
Volume
39
Issue
10
Pages
924-933
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2153829684
Cited by
40
References
6
FWCI
3.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fatty acids as metabolic mediators in innate immunity. https://app.cochat.ai/papers/10.1111/j.1365-2362.2009.02185.x
The paper
Kopp, A., Gross, P., Falk, W., Bala, M., Weigert, J., Buechler, C., Neumeier, M., Schölmerich, J., & Schäffler, A. (2009). Fatty acids as metabolic mediators in innate immunity. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2009.02185.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.